The biological properties of E6 and E7 oncoproteins from human papillomaviruses (original) (raw)
References
E.M. de Villiers, C. Fauquet, T.R. Broker, H.U. Bernard, H. zur Hausen, Classification of papillomaviruses. Virology 324, 17 (2004) ArticlePubMedCAS Google Scholar
H. zur Hausen, Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2, 342 (2002) ArticleCASPubMed Google Scholar
Z. Chen, M. Schiffman, R. Herrero, R. Desalle, R.D. Burk, Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses. Virology 360, 447 (2007) ArticleCASPubMed Google Scholar
R.J. Nobre, E. Herraez-Hernandez, J.W. Fei, L. Langbein, S. Kaden, H.J. Grone, E.M. de Villiers, E7 oncoprotein of novel human papillomavirus type 108 lacking the E6 gene induces dysplasia in organotypic keratinocyte cultures. J. Virol. 83, 2907 (2009) ArticleCASPubMedPubMed Central Google Scholar
N. Munoz, F.X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K.V. Shah, P.J. Snijders, C.J. Meijer, Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348, 518 (2003) ArticlePubMed Google Scholar
J.S. Smith, L. Lindsay, B. Hoots, J. Keys, S. Franceschi, R. Winer, G.M. Clifford, Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int. J. Cancer 121, 621 (2007) ArticleCASPubMed Google Scholar
A.R. Kreimer, G.M. Clifford, P. Boyle, S. Franceschi, Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol. Biomarkers Prev. 14, 467 (2005) ArticleCASPubMed Google Scholar
A.G. Ostor, Natural history of cervical intraepithelial neoplasia: a critical review. Int. J. Gynecol. Pathol. 12, 186 (1993) ArticleCASPubMed Google Scholar
N. Jones, Transcriptional regulation by dimerization: two sides to an incestuous relationship. Cell 61, 9 (1990) ArticleCASPubMed Google Scholar
P.K. Magnusson, P. Sparen, U.B. Gyllensten, Genetic link to cervical tumours. Nature 400, 6729 (1999) ArticleCAS Google Scholar
V. Moreno, N. Munoz, F.X. Bosch, S. de Sanjose, L.C. Gonzalez, L. Tafur, M. Gili, I. Izarzugaza, C. Navarro, A. Vergara et al., Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer. Cancer Epidemiol. Biomarkers Prev. 4, 459 (1995) CASPubMed Google Scholar
V. Moreno, F.X. Bosch, N. Munoz, C.J. Meijer, K.V. Shah, J.M. Walboomers, R. Herrero, S. Franceschi, Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 359, 1085 (2002) ArticleCASPubMed Google Scholar
N. Munoz, S. Franceschi, C. Bosetti, V. Moreno, R. Herrero, J.S. Smith, K.V. Shah, C.J. Meijer, F.X. Bosch, Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 359, 1093 (2002) ArticlePubMed Google Scholar
M.H. Schiffman, N.J. Haley, J.S. Felton, A.W. Andrews, R.A. Kaslow, W.D. Lancaster, R.J. Kurman, L.A. Brinton, L.B. Lannom, D. Hoffmann, Biochemical epidemiology of cervical neoplasia: measuring cigarette smoke constituents in the cervix. Cancer Res. 47, 3886 (1987) CASPubMed Google Scholar
H. Pfister, Chapter 8: human papillomavirus and skin cancer. J. Natl. Cancer Inst. Monogr. 31, 52 (2003) Article Google Scholar
M.N. de Koning, S.J. Weissenborn, D. Abeni, J.N. Bouwes Bavinck, S. Euvrard, A.C. Green, C.A. Harwood, L. Naldi, R. Neale, I. Nindl, C.M. Proby, W.G. Quint, F. Sampogna, J. Ter Schegget, L. Struijk, U. Wieland, H.J. Pfister, M.C. Feltkamp, Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma. J. Gen. Virol. 90, 1611 (2009) ArticlePubMedCAS Google Scholar
H.N. Ananthaswamy, S.M. Loughlin, P. Cox, R.L. Evans, S.E. Ullrich, M.L. Kripke, Sunlight and skin cancer: inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens. Nat. Med. 3, 510 (1997) ArticleCASPubMed Google Scholar
B.K. Armstrong, A. Kricker, The epidemiology of UV induced skin cancer. J. Photochem. Photobiol. B 63, 8 (2001) ArticleCASPubMed Google Scholar
D.S. Preston, R.S. Stern, Nonmelanoma cancers of the skin. N. Engl. J. Med. 327, 1649 (1992) ArticleCASPubMed Google Scholar
C. Ateenyi-Agaba, E. Weiderpass, A. Smet, W. Dong, M. Dai, B. Kahwa, H. Wabinga, E. Katongole-Mbidde, S. Franceschi, M. Tommasino, Epidermodysplasia verruciformis human papillomavirus types and carcinoma of the conjunctiva: a pilot study. Br. J. Cancer 90, 1777 (2004) ArticleCASPubMedPubMed Central Google Scholar
E. Schwarz, U.K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, A. Stremlau, H. zur Hausen, Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314, 111 (1985) ArticleCASPubMed Google Scholar
N. Wentzensen, S. Vinokurova, M. von Knebel Doeberitz, Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res. 64, 3878 (2004) ArticleCASPubMed Google Scholar
L.M. Alvarez-Salas, J.A. DiPaolo, Molecular approaches to cervical cancer therapy. Curr. Drug Discov. Technol. 4, 208 (2007) ArticleCASPubMed Google Scholar
M. Tommasino, L. Crawford, Human papillomavirus E6 and E7: proteins which deregulate the cell cycle. Bioessays 17, 509 (1995) ArticleCASPubMed Google Scholar
P.F. Lambert, S.J. Balsitis, A. Shai, S.J.S. Simonson, S.M.G. Williams, Transgenic mouse models for the in vivo analysis of papillomavirus oncogene function, in Papillomavirus Research: From Natural History to Vaccine and Beyond, ed. by M. Saveria Campo (Caister Academic Press, Norfolk, 2006), pp. 213–228 Google Scholar
M. Tommasino, R. Accardi, S. Caldeira, W. Dong, I. Malanchi, A. Smet, I. Zehbe, The role of TP53 in cervical carcinogenesis. Hum. Mutat. 21, 307 (2003) ArticleCASPubMed Google Scholar
J.M. Huibregtse, M. Scheffner, P.M. Howley, A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10, 4129 (1991) ArticleCASPubMedPubMed Central Google Scholar
M. Scheffner, B.A. Werness, J.M. Huibregtse, A.J. Levine, P.M. Howley, The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129 (1990) ArticleCASPubMed Google Scholar
M. Scheffner, J.M. Huibregtse, R.D. Vierstra, P.M. Howley, The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495 (1993) ArticleCASPubMed Google Scholar
P. Massimi, A. Shai, P. Lambert, L. Banks, HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background. Oncogene 27, 1800 (2008) ArticleCASPubMed Google Scholar
T. Hiller, S. Poppelreuther, F. Stubenrauch, T. Iftner, Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification. Cancer Epidemiol. Biomarkers Prev. 15, 1262 (2006) ArticleCASPubMed Google Scholar
M.S. Lechner, L.A. Laimins, Inhibition of p53 DNA binding by human papillomavirus E6 proteins. J. Virol. 68, 4262 (1994) CASPubMedPubMed Central Google Scholar
K. Butz, C. Denk, A. Ullmann, M. Scheffner, F. Hoppe-Seyler, Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein. Proc. Natl. Acad. Sci. USA 97, 6693 (2000) ArticleCASPubMed Google Scholar
H.C. Pan, A.E. Griep, Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes Dev. 9, 2157 (1995) ArticleCASPubMed Google Scholar
A.E. White, E.M. Livanos, T.D. Tlsty, Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev. 8, 666 (1994) ArticleCASPubMed Google Scholar
U.M. Moll, S. Erster, A. Zaika, p53, p63 and p73—solos, alliances and feuds among family members. Biochim. Biophys. Acta 1552, 47 (2001) CASPubMed Google Scholar
J.S. Park, E.J. Kim, J.Y. Lee, H.S. Sin, S.E. NamKoong, S.J. Um, Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins. Int. J. Cancer 91, 822 (2001) ArticleCASPubMed Google Scholar
M.C. Marin, C.A. Jost, M.S. Irwin, J.A. DeCaprio, D. Caput, W. G. Kaelin Jr., Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol. Cell. Biol. 18, 6316 (1998) ArticleCASPubMedPubMed Central Google Scholar
D. Patel, S.M. Huang, L.A. Baglia, D.J. McCance, The E6 protein of human papillomavirus type 16 binds to and inhibits co- activation by CBP and p300. EMBO J. 18, 5061 (1999) ArticleCASPubMedPubMed Central Google Scholar
A. Muller-Schiffmann, J. Beckmann, G. Steger, The E6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms. J. Virol. 80, 8718 (2006) ArticlePubMedPubMed CentralCAS Google Scholar
D. Gardiol, C. Kuhne, B. Glaunsinger, S.S. Lee, R. Javier, L. Banks, Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18, 5487 (1999) ArticleCASPubMed Google Scholar
L. Funke, S. Dakoji, D.S. Bredt, Membrane-associated guanylate kinases regulate adhesion and plasticity at cell junctions. Annu. Rev. Biochem. 74, 219 (2005) ArticleCASPubMed Google Scholar
M.L. Nguyen, M.M. Nguyen, D. Lee, A.E. Griep, P.F. Lambert, The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6’s induction of epithelial hyperplasia in vivo. J. Virol. 77, 6957 (2003) ArticleCASPubMedPubMed Central Google Scholar
R.A. Watson, M. Thomas, L. Banks, S. Roberts, Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes. J. Cell Sci. 116, 4925 (2003) ArticleCASPubMed Google Scholar
S. Jackson, C. Harwood, M. Thomas, L. Banks, A. Storey, Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev. 14, 3065 (2000) ArticleCASPubMedPubMed Central Google Scholar
M. Thomas, L. Banks, Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene 17, 2943 (1998) ArticleCASPubMed Google Scholar
A.A. Borbely, M. Murvai, J. Konya, Z. Beck, L. Gergely, F. Li, G. Veress, Effects of human papillomavirus type 16 oncoproteins on surviving gene expression. J. Gen. Virol. 87, 287 (2006) ArticleCASPubMed Google Scholar
M.A. James, J.H. Lee, A.J. Klingelhutz, Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner. J. Virol. 80, 5301 (2006) ArticleCASPubMedPubMed Central Google Scholar
H. Yuan, F. Fu, J. Zhuo, W. Wang, J. Nishitani, D.S. An, I.S. Chen, X. Liu, Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis. Oncogene 24, 5069 (2005) ArticleCASPubMed Google Scholar
A.J. Klingelhutz, S.A. Foster, J.K. McDougall, Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380, 79 (1996) ArticleCASPubMed Google Scholar
J.W. Shay, W.E. Wright, Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 26, 867 (2005) ArticleCASPubMed Google Scholar
L. Gewin, H. Myers, T. Kiyono, D.A. Galloway, Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev. 18, 2269 (2004) ArticleCASPubMedPubMed Central Google Scholar
K.M. Bedard, M.P. Underbrink, H.L. Howie, D.A. Galloway, The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes. J. Virol. 82, 3894 (2008) ArticleCASPubMedPubMed Central Google Scholar
X. Liu, H. Yuan, B. Fu, G.L. Disbrow, T. Apolinario, V. Tomaic, M.L. Kelley, C.C. Baker, J. Huibregtse, R. Schlegel, The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein. J. Biol. Chem. 280, 10807 (2005) ArticleCASPubMed Google Scholar
T. Veldman, X. Liu, H. Yuan, R. Schlegel, Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc. Natl. Acad. Sci. USA 100, 8211 (2003) ArticleCASPubMed Google Scholar
P. Sekaric, J.J. Cherry, E.J. Androphy, Binding of human papillomavirus type 16 E6 to E6AP is not required for activation of hTERT. J. Virol. 82, 71 (2008) ArticleCASPubMed Google Scholar
X. Liu, J. Roberts, A. Dakic, Y. Zhang, R. Schlegel, HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function. Virology 375, 611 (2008) ArticleCASPubMedPubMed Central Google Scholar
S. Lowell, P. Jones, R. Le, I.J. Dunne, F.M. Watt, Stimulation of human epidermal differentiation by delta-notch signalling at the boundaries of stem-cell clusters. Curr. Biol. 10, 491 (2000) Article Google Scholar
T. Yugawa, K. Handa, M. Narisawa-Saito, S. Ohno, M. Fujita, T. Kiyono, Regulation of Notch1 gene expression by p53 in epithelial cells. Mol. Cell. Biol. 27, 3732 (2007) ArticleCASPubMedPubMed Central Google Scholar
C. Talora, D.C. Sgroi, C.P. Crum, G.P. Dotto, Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Genes Dev. 16, 2252 (2002) ArticleCASPubMedPubMed Central Google Scholar
I. Malanchi, S. Caldeira, M. Krutzfeldt, M. Giarre, M. Alunni-Fabbroni, M. Tommasino, Identification of a novel activity of human papillomavirus type 16 E6 protein in deregulating the G1/S transition. Oncogene 21, 5665 (2002) ArticleCASPubMed Google Scholar
I. Malanchi, R. Accardi, F. Diehl, A. Smet, E. Androphy, J. Hoheisel, M. Tommasino, Human papillomavirus type 16 E6 promotes retinoblastoma protein phosphorylation and cell cycle progression. J. Virol. 78, 13769 (2004) ArticleCASPubMedPubMed Central Google Scholar
J. An, D. Mo, H. Liu, M.S. Veena, E.S. Srivatsan, R. Massoumi, M.B. Rettig, Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation. Cancer Cell 14, 394 (2008) ArticleCASPubMedPubMed Central Google Scholar
F. Mantovani, L. Banks, The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20, 7874 (2001) ArticleCASPubMed Google Scholar
S.S. Tungteakkhun, M. Filippova, J.W. Neidigh, N. Fodor, P.J. Duerksen-Hughes, The interaction between human papillomavirus type 16 and FADD is mediated by a novel E6 binding domain. J. Virol. 82, 9600 (2008) ArticleCASPubMedPubMed Central Google Scholar
R.M. Vos, J. Altreuter, E.A. White, P.M. Howley, The ubiquitin-specific peptidase USP15 regulates human papillomavirus type 16 E6 protein stability. J. Virol. 83, 8885 (2009) ArticleCASPubMedPubMed Central Google Scholar
K. Munger, J.R. Basile, S. Duensing, A. Eichten, S.L. Gonzalez, M. Grace, V.L. Zacny, Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20, 7888 (2001) ArticleCASPubMed Google Scholar
D.K. Dimova, N.J. Dyson, The E2F transcriptional network: old acquaintances with new faces. Oncogene 24, 2810 (2005) ArticleCASPubMed Google Scholar
S.G. Hwang, D. Lee, J. Kim, T. Seo, J. Choe, Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner. J. Biol. Chem. 277, 2923 (2002) ArticleCASPubMed Google Scholar
M.J. Antinore, M.J. Birrer, D. Patel, L. Nader, D.J. McCance, The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors. EMBO J. 15, 1950 (1996) ArticleCASPubMedPubMed Central Google Scholar
E. Maldonado, M.E. Cabrejos, L. Banks, J.E. Allende, Human papillomavirus-16 E7 protein inhibits the DNA interaction of the TATA binding transcription factor. J. Cell. Biochem. 85, 663 (2002) ArticleCASPubMed Google Scholar
P. Massimi, D. Pim, L. Banks, Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity. J. Gen. Virol. 78, 2607 (1997) ArticleCASPubMed Google Scholar
A.C. Phillips, K.H. Vousden, Analysis of the interaction between human papillomavirus type 16 E7 and the TATA-binding protein, TBP. J. Gen. Virol. 78, 905 (1997) ArticleCASPubMed Google Scholar
J.O. Funk, S. Waga, J.B. Harry, E. Espling, B. Stillman, D.A. Galloway, Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev. 11, 2090 (1997) ArticleCASPubMedPubMed Central Google Scholar
D.L. Jones, R.M. Alani, K. Munger, The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev. 11, 2101 (1997) ArticleCASPubMedPubMed Central Google Scholar
K. Zerfaß-Thome, W. Zwerschke, B. Mannhardt, R. Tindle, J. Botz, P. Jansen-Dürr, Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 13, 2323 (1996) PubMed Google Scholar
M. Arroyo, S. Bagchi, P. Raychaudhuri, Association of the human papillomavirus type-16 E7 protein with the S-phase-specific E2F-cyclin-A complex. Mol. Cell. Biol. 13, 6537 (1993) ArticleCASPubMedPubMed Central Google Scholar
R. Davies, R. Hicks, T. Crook, J. Morris, K. Vousden, Human papillomavirus type-16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J. Virol. 67, 2521 (1993) CASPubMedPubMed Central Google Scholar
M. Tommasino, J.P. Adamczewski, F. Carlotti, C.F. Barth, R. Manetti, M. Contorni, F. Cavalieri, T. Hunt, L. Crawford, HPV16 E7 protein associates with the protein kinase p33CDK2 and cyclin A. Oncogene 8, 195 (1993) CASPubMed Google Scholar
W. He, D. Staples, C. Smith, C. Fisher, Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7. J. Virol. 77, 10566 (2003) ArticleCASPubMedPubMed Central Google Scholar
K. Munger, B.A. Werness, N. Dyson, W.C. Phelps, E. Harlow, P.M. Howley, Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8, 4099 (1989) ArticleCASPubMedPubMed Central Google Scholar
D.V. Heck, C.L. Yee, P.M. Howley, K. Munger, Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc. Natl. Acad. Sci. USA 89, 4442 (1992) ArticleCASPubMed Google Scholar
B.C. Sang, M.S. Barbosa, Single amino acid substitutions in “low-risk” human papillomavirus (HPV) type 6 E7 protein enhance features characteristic of the “high-risk” HPV E7 oncoproteins. Proc. Natl. Acad. Sci. USA 89, 8063 (1992) ArticleCASPubMed Google Scholar
S. Caldeira, W. Dong, P. Tomakidi, A. Paradiso, M. Tommasino, Human papillomavirus type 32 does not display in vitro transforming properties. Virology 301, 157 (2002) ArticleCASPubMed Google Scholar
F. Ciccolini, G. Di Pasquale, F. Carlotti, L. Crawford, M. Tommasino, Functional studies of E7 proteins from different HPV types. Oncogene 9, 2342 (1994) Google Scholar
W.L. Dong, S. Caldeira, P. Sehr, M. Pawlita, M. Tommasino, Determination of the binding affinity of different human papillomavirus E7 proteins for the tumour suppressor pRb by a plate-binding assay. J. Virol. Methods 98, 91 (2001) ArticleCASPubMed Google Scholar
A. Schmitt, J.B. Harry, B. Rapp, F.O. Wettstein, T. Iftner, Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1. J. Virol. 68, 7051 (1994) CASPubMedPubMed Central Google Scholar
S.N. Boyer, D.E. Wazer, V. Band, E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 56, 4620 (1996) CASPubMed Google Scholar
D.L. Jones, K. Munger, Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J. Virol. 71, 2905 (1997) CASPubMedPubMed Central Google Scholar
M. Giarre, S. Caldeira, I. Malanchi, F. Ciccolini, M.J. Leao, M. Tommasino, Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle arrest. J. Virol. 75, 4705 (2001) ArticleCASPubMedPubMed Central Google Scholar
S.L. Gonzalez, M. Stremlau, X. He, J.R. Basile, K. Munger, Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J. Virol. 75, 7583 (2001) ArticleCASPubMedPubMed Central Google Scholar
G.A. Darnell, W.A. Schroder, T.M. Antalis, E. Lambley, L. Major, J. Gardner, G. Birrell, A. Cid-Arregui, A. Suhrbier, Human papillomavirus E7 requires the protease calpain to degrade the retinoblastoma protein. J. Biol. Chem. 282, 37492 (2007) ArticleCASPubMed Google Scholar
K. Huh, X. Zhou, H. Hayakawa, J.Y. Cho, T.A. Libermann, J. Jin, J.W. Harper, K. Munger, Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J. Virol. 81, 9737 (2007) ArticleCASPubMedPubMed Central Google Scholar
S.J. Reshkin, A. Bellizzi, S. Caldeira, V. Albarani, I. Malanchi, M. Poignee, M. Alunni-Fabbroni, V. Casavola, M. Tommasino, Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J. 14, 2185 (2000) ArticleCASPubMed Google Scholar
M.E. McLaughlin-Drubin, K. Munger, The human papillomavirus E7 oncoprotein. Virology 384, 335 (2009) ArticleCASPubMed Google Scholar
A.C. Rodriguez, M. Schiffman, R. Herrero, S. Wacholder, A. Hildesheim, P.E. Castle, D. Solomon, R. Burk, Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J. Natl. Cancer Inst. 100, 513 (2008) ArticlePubMedPubMed Central Google Scholar
M.H. Einstein, J.T. Schiller, R.P. Viscidi, H.D. Strickler, P. Coursaget, T. Tan, N. Halsey, D. Jenkins, Clinician’s guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect. Dis. 9, 347 (2009) ArticleCASPubMed Google Scholar
U.A. Hasan, E. Bates, F. Takeshita, A. Biliato, R. Accardi, V. Bouvard, M. Mansour, I. Vincent, L. Gissmann, T. Iftner, M. Sideri, F. Stubenrauch, M. Tommasino, TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J. Immunol. 178, 3186 (2007) ArticleCASPubMed Google Scholar
L.V. Ronco, A.Y. Karpova, M. Vidal, P.M. Howley, Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12, 2061 (1998) ArticleCASPubMedPubMed Central Google Scholar
J.S. Park, E.J. Kim, H.J. Kwon, E.S. Hwang, S.E. NamKoong, S.J. Um, Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J. Biol. Chem. 275, 6764 (2000) ArticleCASPubMed Google Scholar
S.E. Perea, P. Massimi, L. Banks, Human papillomavirus type 16 E7 impairs the activation of the interferon regulatory factor-1. Int. J. Mol. Med. 5, 661 (2000) CASPubMed Google Scholar
J.H. Caberg, P.M. Hubert, D.Y. Begon, M.F. Herfs, P.J. Roncarati, J.J. Boniver, P.O. Delvenne, Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes. Carcinogenesis 29, 1441 (2008) ArticleCASPubMed Google Scholar
P. Hubert, J.H. Caberg, C. Gilles, L. Bousarghin, E. Franzen-Detrooz, J. Boniver, P. Delvenne, E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions. J. Pathol. 206, 346 (2005) ArticleCASPubMed Google Scholar
F.V. Cromme, P.J. Snijders, A.J. van den Brule, P. Kenemans, C.J. Meijer, J.M. Walboomers, MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpression. Oncogene 8, 2969 (1993) CASPubMed Google Scholar
A. Vambutas, V.R. Bonagura, B.M. Steinberg, Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis: correlation of TAP-1 with disease. Clin. Diagn. Lab. Immunol. 7, 79 (2000) CASPubMedPubMed Central Google Scholar
A. Vambutas, J. DeVoti, W. Pinn, B.M. Steinberg, V.R. Bonagura, Interaction of human papillomavirus type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport. Clin. Immunol. 101, 94 (2001) ArticleCASPubMed Google Scholar
F. Mota, N. Rayment, S. Chong, A. Singer, B. Chain, The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. Clin. Exp. Immunol. 116, 33 (1999) ArticleCASPubMedPubMed Central Google Scholar
L.L. Villa, K.B. Vieira, X.F. Pei, R. Schlegel, Differential effect of tumor necrosis factor on proliferation of primary human keratinocytes and cell lines containing human papillomavirus types 16 and 18. Mol. Carcinog. 6, 5 (1992) ArticleCASPubMed Google Scholar